The potency of dexamethasone conjugated to an anti-CD163 antibody was shown to be 50-fold higher compared to non-conjugated dexamethasone in in vivo endotoxemia models in both rat and pig [302,305]. The gene discussed is CD163; the disease is serum lipopolysaccharide activity.